Role of cholesterol metabolism in the pathogenesis of Alzheimerʼs disease
Authors:
- Christine ClamagirandCCChristine Clamagirand
- Marie-Claude PotierMPMarie-Claude Potier
- 1 July 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 17 (4) , 319-323
Abstract
Cholesterol has been shown to stimulate the cleavage of amyloid precursor protein (APP) into amyloid peptides involved in Alzheimer's disease. However, high level of peripheral cholesterol as a risk factor for Alzheimer's disease is still debated. This current review provides an update of the recent literature on cholesterol and APP metabolisms in the brain. First, a new relationship between neuronal APP and cholesterol has been shown in which this protein controls cholesterol turnover required for neuronal activity. Second, oxysterols are able to stimulate the synthesis of ATP-binding cassette transporters involved in the exchange of amyloid peptides between the blood and the brain. Third, changes in APP targeting to lipid rafts and/or their composition in cholesterol regulate amyloid peptide production. These recent findings open new areas of investigations to control the neuronal activity and to decrease the amyloid peptide levels in brain, opening on new preventive and therapeutic strategies for Alzheimer's disease.Keywords
This publication has 25 references indexed in Scilit:
- Associations Between Serum Cholesterol Levels and Cerebral AmyloidosisJAMA Neurology, 2014
- Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's diseaseBiochemical Pharmacology, 2013
- Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cellsBrain Research, 2013
- ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditionsProceedings of the National Academy of Sciences of the United States of America, 2013
- Brain Pericytes ABCA1 Expression Mediates Cholesterol Efflux but not Cellular Amyloid-β Peptide AccumulationJournal of Alzheimer’s Disease, 2012
- Processing of Endogenous AβPP in Blood-Brain Barrier Endothelial Cells is Modulated by Liver-X Receptor Agonists and Altered Cellular Cholesterol HomeostasisJournal of Alzheimer’s Disease, 2011
- Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide ClearanceScience Translational Medicine, 2011
- Alzheimer's DiseaseCold Spring Harbor Perspectives in Biology, 2011
- Local cholesterol increase triggers amyloid precursor protein‐Bacel clustering in lipid rafts and rapid endocytosisThe FASEB Journal, 2011
- Clathrin-dependent APP endocytosis and Aβ secretion are highly sensitive to the level of plasma membrane cholesterolBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010